Dalan Animal Health: Pioneering Vaccines for Bees and Shrimp

The Importance of Animal Biotech

• 🐝 Honeybees are crucial pollinators for nutritious foods like almonds and pumpkins, making their health vital for our food supply.
• 🦐 The shrimp industry, a significant global market, faces billions in annual losses due to diseases, highlighting the need for innovative solutions.
• 💡 Animal biotech extends beyond companion animals and livestock to include essential species like insects and crustaceans, playing a critical role in food security and biodiversity.

Dalan Animal Health's Bee Vaccine Innovation

• 🔬 Dalan Animal Health developed the world's first vaccine for honeybees to combat diseases that threaten their populations.
• 👑 The vaccine is administered orally to the queen bee via a sugar paste, which then passes immunity to her offspring.
• 🧬 This method leverages a natural insect phenomenon where maternal animals transfer disease information to the next generation, upregulating the larvae's immune system.

Navigating Funding and Commercialization Challenges

• 🗺️ Dalan Animal Health initially faced challenges finding investors, as bee vaccines didn't fit traditional animal health or food tech investment themes.
• 💰 Funding was primarily secured through angel investors and later through climate and sustainability-focused VCs who recognized the ecological importance of their work.
• 📈 The company is creating a new playbook for developing, licensing, and commercializing products for underserved animal markets, building the distribution channels from scratch.

Expanding to Shrimp Vaccines

• 🍤 Dalan is now developing a vaccine for shrimp, a market with well-documented economic losses due to diseases like White Spot Syndrome.
• 📊 The shrimp industry offers clearer market data and a more understood risk profile, making it easier to attract investment and commercialize compared to bee vaccines.
• 🌍 The goal is to reduce reliance on antibiotics and chemicals in shrimp farming, making it a more sustainable protein source.

The Landscape of Science Funding

• 🇺🇸 While US capital markets remain strong, the company has largely avoided government grants to maintain focus and avoid political distractions.
• 🇪🇺 European Union innovation funding is significant and competitive, supporting research in the region.
• 📉 Investors are currently more cautious, focusing on de-risking investments and assessing market viability, a shift from the more aggressive funding climate of previous years.